HSP90B2P and neoplasm: In preclinical studies, NIR-PIT acts on skin squamous cell carcinoma cells, which swell and rupture, causing rapid and irreversible damage, during which the tumor cells undergo an ICD response, and CRT and HSP expression increases on the cell surface.